Oxford BioMedica to Present at 2nd Annual Regen Med Investor Day
Oxford, UK – 21 March 2014: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, announces that John Dawson, Chief Executive Officer, will present…